Stockscreener 앱 받기
0.5149
0.66%
0.0034
시간 외 거래:
.50
-0.0149
-2.89%
전일 마감가:
$0.5115
열려 있는:
$0.5096
하루 거래량:
381.62K
Relative Volume:
0.26
시가총액:
$36.61M
수익:
$391.70K
순이익/손실:
$-52.34M
주가수익비율:
-0.6865
EPS:
-0.75
순현금흐름:
$-45.92M
1주 성능:
+2.98%
1개월 성능:
+19.74%
6개월 성능:
-23.15%
1년 성능:
-43.73%
1일 변동 폭
$0.50
$0.535
1주일 범위
$0.475
$0.535
52주 변동 폭
$0.2425
$1.47
Ovid Therapeutics Inc Stock (OVID) Company Profile
명칭
Ovid Therapeutics Inc
전화
212-776-4381
주소
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
OVID을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OVID
Ovid Therapeutics Inc
|
0.5149 | 36.28M | 391.70K | -52.34M | -45.92M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-18 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-04-30 | 개시 | B. Riley Securities | Buy |
| 2024-04-29 | 개시 | H.C. Wainwright | Buy |
| 2024-04-05 | 개시 | Wedbush | Outperform |
| 2023-12-21 | 개시 | BTIG Research | Buy |
| 2023-10-13 | 개시 | Oppenheimer | Outperform |
| 2021-04-20 | 다운그레이드 | Cantor Fitzgerald | Buy → Neutral |
| 2021-03-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2018-04-20 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Ovid Therapeutics Inc 주식(OVID)의 최신 뉴스
Ovid Therapeutics OVID 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Ovid Therapeutics Maintains Buy Rating with $3.00 Price Target from B.Riley Financial Analyst Madison Elsaadi. - AInvest
B.Riley assumes coverage on Ovid Therapeutics stock with Buy rating - Investing.com Australia
Ovid Therapeutics Inc. Stock Analysis and ForecastMarket-crushing profits - Jammu Links News
What are analysts’ price targets for Ovid Therapeutics Inc. in the next 12 monthsUnlock powerful trading signals and alerts - Jammu Links News
Is it the right time to buy Ovid Therapeutics Inc. stockOutstanding capital growth - Jammu Links News
Does Ovid Therapeutics Inc. stock perform well during market downturnsAchieve rapid wealth accumulation with smart picks - Jammu Links News
What makes Ovid Therapeutics Inc. stock price move sharplyGet real-time alerts on high-potential stocks - Jammu Links News
Is Ovid Therapeutics Inc. stock overvalued or undervaluedTremendous financial leverage - jammulinksnews.com
Should I hold or sell Ovid Therapeutics Inc. stock in 2025Invest smarter with actionable stock recommendations - Jammu Links News
What institutional investors are buying Ovid Therapeutics Inc. stockBuild a balanced portfolio for long-term success - Jammu Links News
How strong is Ovid Therapeutics Inc. company’s balance sheetMaximize gains with strategic stock entries - Jammu Links News
How does Ovid Therapeutics Inc. compare to its industry peersFree Wealth Planning Blueprint - Jammu Links News
Why is Ovid Therapeutics Inc. stock attracting strong analyst attentionSuperior stock growth - Jammu Links News
What is the dividend policy of Ovid Therapeutics Inc. stockUnrivaled growth potential - Jammu Links News
What are the technical indicators suggesting about Ovid Therapeutics Inc.Take advantage of unprecedented market momentum - Jammu Links News
Will Ovid Therapeutics Inc. price bounce be sustainableFree Fast Gaining Stock Screener Report - Newser
Is Ovid Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis Inside - Newser
Short interest data insights for Ovid Therapeutics Inc.Summary of Reliable Long-Term Trade Models - Newser
What technical models suggest about Ovid Therapeutics Inc.’s comebackHigh Accuracy Trade Setup Identification - Newser
Ovid Therapeutics Inc (OVID) Stock: A Year of Market Movement, Down and Up - investchronicle.com
Is Ovid Therapeutics Inc. stock poised for growthTrade Setup Builder with Custom Alerts - Newser
Multi asset correlation models including Ovid Therapeutics Inc.Free Secure Capital Picks With Upside Potential - Newser
Combining price and volume data for Ovid Therapeutics Inc.Buy Strategy with Smart Exit Timing - Newser
Identifying reversal signals in Ovid Therapeutics Inc.Low Volatility Stock Analysis With Confidence - Newser
Why Ovid Therapeutics Inc. stock attracts strong analyst attentionBear Market Safe Zone Technical Analysis - Newser
Quantitative breakdown of Ovid Therapeutics Inc. recent moveDaily Exit and Entry Price Prediction - Newser
Ovid Therapeutics Inc. Stock Support and Resistance Levels You Should KnowWeekly Gain Forecast with Momentum Indicators - Newser
Published on: 2025-07-30 02:43:14 - beatles.ru
Institutional Tools Highlight Unusual Flow in Ovid Therapeutics Inc.Breakout Momentum Picks With Protection Outlined - metal.it
Analyzing Ovid Therapeutics Inc. with multi timeframe chartsConsistent Profit Signals with AI Models - Newser
Published on: 2025-07-29 00:10:51 - metal.it
Published on: 2025-07-28 19:38:56 - metal.it
Has Ovid Therapeutics Inc. formed a bullish divergenceEarnings Play Trade Plan With Alerts Shared - metal.it
Ovid Therapeutics Inc (OVID) Stock: A Comprehensive 52-Week Review - investchronicle.com
Using R and stats models for Ovid Therapeutics Inc. forecastingBuy and Hold Return Summary with Charts - Newser
How Ovid Therapeutics Inc. stock performs during market volatilityEarnings Impact and Stock Reaction Analysis - Newser
Ovid Therapeutics Inc (OVID) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):